Halozyme Therapeutics Inc (NASDAQ:HALO)

15.07
Delayed Data
As of Feb 27
 -0.21 / -1.37%
Today’s Change
6.88
Today|||52-Week Range
15.94
+56.17%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Engler Robert L
Director
Sale5/15/2014126,700$7.56$957.9K+96.74%
Patton John Stuart
Director
Sale8/19/201475,000$9.96$747.0K+50.40%
Engler Robert L
Director
Buy5/15/2014150,000$4.10$615.0K+96.74%
Torley Helen I
President & Chief Executive Officer
Buy9/16/201450,000$8.92$446.0K+66.70%
Engler Robert L
Director
Sale8/14/201435,000$9.96$348.6K+51.15%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201425,000$8.90$222.5K+66.70%
Engler Robert L
Director
Buy8/14/201475,000$2.05$153.8K+51.15%
Patton John Stuart
Director
Buy8/19/201475,000$2.05$153.8K+50.40%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201511,919$10.06$119.9K+49.80%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201450,000$2.05$102.5K+66.70%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account